Details of the Drug Formulations

General Information of Drug (ID: DMC0GSJ)

Drug Name
Efavirenz Drug Info
Synonyms
EFV; EFZ; Eravirenz; Stocrin; Sustiva; DMP 266; L 743726; DMP-266; L-741211; L-743725; L-743726; Stocrin (TN); Strocin (TM); Sustiva (TM); Sustiva (TN); Efavirenz (JAN/INN); L-743,726; Zoxazin-2-one; Efavirenz, (S)-isomer; Met-SDF-1.beta. & Efavirenz; Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz; (-)-Efavirenz; (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben; (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9; 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Approved [1]
Therapeutic Class
Anti-HIV Agents
Cross-matching ID
PubChem CID
64139
ChEBI ID
CHEBI:119486
CAS Number
154598-52-4
TTD ID
D07HVY
VARIDT ID
DR00412
INTEDE ID
DR0560
ACDINA ID
D00222

Full List of Drug Formulations Containing This Drug

Efavirenz 200 mg capsule
Company Formulation ID FDA Description
Bristol-Myers Squibb Company F07176 Lactose monohydrate; Sodium lauryl sulfate; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Gelatin; Sodium starch glycolate type a potato
Aurobindo Pharma; Rising Pharmaceuticals F07177 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Silicon dioxide; Gelatin; Shellac; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------
Efavirenz 50 mg capsule
Company Formulation ID FDA Description
Bristol-Myers Squibb Company F07178 Lactose monohydrate; Sodium lauryl sulfate; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Gelatin; Sodium starch glycolate type a potato
Aurobindo Pharma; Rising Pharmaceuticals F07179 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Gelatin; Shellac; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------
Efavirenz 100 mg capsule
Company Formulation ID FDA Description
Aurobindo Pharma F07175 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Gelatin; Shellac; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------
Efavirenz 600 mg tablet
Company Formulation ID FDA Description
Physicians Total Care F07180 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Croscarmellose sodium; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose
RemedyRepack F07181 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Croscarmellose sodium; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
------------------------------------------------------------------------------------

References

1 Approved antiretroviral drugs. Antiretroviral Drugs. Company report of AVERT. 2009.